These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38124732)

  • 61. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bioinformatics analyses of combined databases identify shared differentially expressed genes in cancer and autoimmune disease.
    Sui Y; Li S; Fu XQ; Zhao ZJ; Xing S
    J Transl Med; 2023 Feb; 21(1):109. PubMed ID: 36765396
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
    Aue A; Szelinski F; Weißenberg SY; Wiedemann A; Rose T; Lino AC; Dörner T
    Rheumatology (Oxford); 2020 Nov; 59(11):3435-3442. PubMed ID: 32357246
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway.
    Yeung KS; Chung BH; Choufani S; Mok MY; Wong WL; Mak CC; Yang W; Lee PP; Wong WH; Chen YA; Grafodatskaya D; Wong RW; Lau CS; Chan DT; Weksberg R; Lau YL
    PLoS One; 2017; 12(1):e0169553. PubMed ID: 28085900
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Case Report: Response of cutaneous lupus lesions in SLE to interferon receptor blockade parallels reduction of interferon score in blood.
    Günther C; Wolf C; Fennen L; Rösing S; Beissert S; Aringer M; Lee-Kirsch MA
    Front Immunol; 2023; 14():1253279. PubMed ID: 37809086
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs).
    Mathian A; Felten R; Alarcon-Riquelme ME; Psarras A; Mertz P; Chasset F; Vital EM; Arnaud L
    Joint Bone Spine; 2024 Mar; 91(2):105627. PubMed ID: 37640261
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Type I interferon gene signature test-low and -high patients with systemic lupus erythematosus have distinct gene expression signatures.
    Brohawn PZ; Streicher K; Higgs BW; Morehouse C; Liu H; Illei G; Ranade K
    Lupus; 2019 Nov; 28(13):1524-1533. PubMed ID: 31660791
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus.
    Casey KA; Smith MA; Sinibaldi D; Seto NL; Playford MP; Wang X; Carlucci PM; Wang L; Illei G; Yu B; Wang S; Remaley AT; Mehta NN; Kaplan MJ; White WI
    Arthritis Rheumatol; 2021 Mar; 73(3):459-471. PubMed ID: 32909675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. JAK inhibitors and autoimmune rheumatic diseases.
    Benucci M; Bernardini P; Coccia C; De Luca R; Levani J; Economou A; Damiani A; Russo E; Amedei A; Guiducci S; Bartoloni E; Manfredi M; Grossi V; Infantino M; Perricone C
    Autoimmun Rev; 2023 Apr; 22(4):103276. PubMed ID: 36649877
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Activation of JAK-STAT1 signal transduction pathway in lesional skin and monocytes from patients with systemic lupus erythematosus.
    Li J; Zhao S; Yi M; Hu X; Li J; Xie H; Zhu W; Chen M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):109-15. PubMed ID: 21368418
    [TBL] [Abstract][Full Text] [Related]  

  • 71. STS-1 promotes IFN-α induced autophagy by activating the JAK1-STAT1 signaling pathway in B cells.
    Dong G; You M; Fan H; Ding L; Sun L; Hou Y
    Eur J Immunol; 2015 Aug; 45(8):2377-88. PubMed ID: 25959715
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comprehensive assessment of the association between genes on JAK-STAT pathway (IFIH1, TYK2, IL-10) and systemic lupus erythematosus: a meta-analysis.
    Yin Q; Wu LC; Zheng L; Han MY; Hu LY; Zhao PP; Bai WY; Zhu XW; Xia JW; Wang XB; Zhang XW; Zheng HF
    Arch Dermatol Res; 2018 Nov; 310(9):711-728. PubMed ID: 30171347
    [TBL] [Abstract][Full Text] [Related]  

  • 73. T Cells Produce IFN-α in the TREX1 D18N Model of Lupus-like Autoimmunity.
    Simpson SR; Rego SL; Harvey SE; Liu M; Hemphill WO; Venkatadri R; Sharma R; Grayson JM; Perrino FW
    J Immunol; 2020 Jan; 204(2):348-359. PubMed ID: 31826941
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus.
    Zhu H; Mi W; Luo H; Chen T; Liu S; Raman I; Zuo X; Li QZ
    Arthritis Res Ther; 2016 Jul; 18():162. PubMed ID: 27412348
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Photosensitivity and cGAS-Dependent IFN-1 Activation in Patients with Lupus and TREX1 Deficiency.
    Berndt N; Wolf C; Fischer K; Cura Costa E; Knuschke P; Zimmermann N; Schmidt F; Merkel M; Chara O; Lee-Kirsch MA; Günther C
    J Invest Dermatol; 2022 Mar; 142(3 Pt A):633-640.e6. PubMed ID: 34400195
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of genetic variation near interferon-kappa in systemic lupus erythematosus.
    Harley IT; Niewold TB; Stormont RM; Kaufman KM; Glenn SB; Franek BS; Kelly JA; Kilpatrick JR; Hutchings D; Divers J; Bruner GR; Edberg JC; McGwin G; Petri MA; Ramsey-Goldman R; Reveille JD; Vilá-Pérez LM; Merrill JT; Gilkeson GS; Vyse TJ; Alarcón-Riquelme ME; Cho SK; Jacob CO; Alarcón GS; Moser KL; Gaffney PM; Kimberly RP; Bae SC; Langefeld CD; Harley JB; Guthridge JM; James JA
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20706608
    [TBL] [Abstract][Full Text] [Related]  

  • 77. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.
    Hellquist A; Järvinen TM; Koskenmies S; Zucchelli M; Orsmark-Pietras C; Berglind L; Panelius J; Hasan T; Julkunen H; D'Amato M; Saarialho-Kere U; Kere J
    J Rheumatol; 2009 Aug; 36(8):1631-8. PubMed ID: 19567624
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus.
    Huo R; Huang X; Yang Y; Lin J
    J Inflamm Res; 2023; 16():1471-1478. PubMed ID: 37051062
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date.
    Felten R; Scher F; Sagez F; Chasset F; Arnaud L
    Drug Des Devel Ther; 2019; 13():1535-1543. PubMed ID: 31190735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.